BR112013020864A2 - métodos para sintetizar derivados de precursor z de molibdopterina - Google Patents

métodos para sintetizar derivados de precursor z de molibdopterina

Info

Publication number
BR112013020864A2
BR112013020864A2 BR112013020864A BR112013020864A BR112013020864A2 BR 112013020864 A2 BR112013020864 A2 BR 112013020864A2 BR 112013020864 A BR112013020864 A BR 112013020864A BR 112013020864 A BR112013020864 A BR 112013020864A BR 112013020864 A2 BR112013020864 A2 BR 112013020864A2
Authority
BR
Brazil
Prior art keywords
methods
formula
molybdopterin
synthesizing
derivatives
Prior art date
Application number
BR112013020864A
Other languages
English (en)
Inventor
Brunner Andreas
Abel Sébastien Landreau Cyrille
Dai Danmei
Kevin Watt Derek
Mary Little Gillian
Clinch Keith
Georges Rene Proisy Nicolas
Anne Dixon Rachel
Myrna Baars Sylvia
Long Xiangtian
Original Assignee
Alexion Pharma Int Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharma Int Sarl filed Critical Alexion Pharma Int Sarl
Publication of BR112013020864A2 publication Critical patent/BR112013020864A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)

Abstract

métodos para sintetizar derivados de precursor z de molibdopterina a presente invenção refere-se a métodos sintéticos para preparar um composto da fórmula (i): também providos aqui são métodos sintéticos para preparar um composto da fórmula (xiii): a descrição também provê intermediários úteis, derivados, profármacos, e sais, solvatos e hidratos farmaceuticamente aceitáveis dos compostos da fórmula (i) e fórmula (xiii). esses compostos são úteis para tratar doenças associadas com deficiência de cofator de molibdênio.
BR112013020864A 2011-02-18 2012-02-17 métodos para sintetizar derivados de precursor z de molibdopterina BR112013020864A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161444280P 2011-02-18 2011-02-18
US201161444399P 2011-02-18 2011-02-18
US201161444389P 2011-02-18 2011-02-18
US201161498801P 2011-06-20 2011-06-20
US201161498808P 2011-06-20 2011-06-20
US201261599314P 2012-02-15 2012-02-15
PCT/US2012/025689 WO2012112922A1 (en) 2011-02-18 2012-02-17 Methods for synthesizing molybdopterin precursor z derivatives

Publications (1)

Publication Number Publication Date
BR112013020864A2 true BR112013020864A2 (pt) 2019-09-24

Family

ID=46672966

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013020864A BR112013020864A2 (pt) 2011-02-18 2012-02-17 métodos para sintetizar derivados de precursor z de molibdopterina

Country Status (16)

Country Link
US (2) US9260462B2 (pt)
EP (1) EP2675278B1 (pt)
JP (1) JP5972911B2 (pt)
KR (1) KR20140007431A (pt)
AR (1) AR085291A1 (pt)
AU (1) AU2012219292B2 (pt)
BR (1) BR112013020864A2 (pt)
CA (1) CA2827679C (pt)
CO (1) CO7071121A2 (pt)
EA (1) EA201391206A1 (pt)
ES (1) ES2569252T3 (pt)
IL (1) IL227917A0 (pt)
MX (1) MX2013009501A (pt)
SG (1) SG192826A1 (pt)
TW (1) TW201241005A (pt)
WO (1) WO2012112922A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG192826A1 (en) 2011-02-18 2013-09-30 Alexion Pharma Internat Sarl Methods for synthesizing molybdopterin precursor z derivatives
WO2016115473A1 (en) * 2015-01-15 2016-07-21 Mayo Foundation For Medical Education And Research Methods of treating neurological inflammatory disorders
WO2017019532A1 (en) 2015-07-24 2017-02-02 Alexion Pharmaceuticals, Inc. Precursor z (cpmp) to treat molybdenum cofactor deficiency type a
SG11201804901WA (en) 2015-12-22 2018-07-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
CA3066939A1 (en) * 2017-06-21 2018-12-27 SHY Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
WO2023227763A1 (en) 2022-05-27 2023-11-30 Arlanxeo Deutschland Gmbh Rubber compounds of functionalized conjugated diene rubbers and silica fillers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4713454A (en) 1985-01-28 1987-12-15 Shiratori Pharmaceutical Co., Ltd. Preparation process of (6R)-tetrahydro-L-biopterin
EP1218512A2 (en) * 1999-06-18 2002-07-03 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
IL153231A0 (en) 2000-06-28 2003-07-06 Smithkline Beecham Plc Wet milling process
US20030207430A1 (en) * 2001-03-01 2003-11-06 Tang Y. Tom Human enzyme molecules
DE102004004642A1 (de) * 2004-01-29 2006-04-27 Schwarz, Guenter, Dr. Produktion, Gewinnung und therapeutischer Einsatz des Molybdopterin-Derivats Precursor Z zur Therapie der Stoffwechselerkrankung humaner Molybdäncofaktor-Defizienz und anderer assoziierter Krankheiten
WO2007052308A2 (en) 2005-11-03 2007-05-10 Brain N' Beyond Biotech Pvt. Ltd. Glyco-phosphorylated biologically active agents
AU2008206486C1 (en) 2007-01-12 2013-09-26 Biomarin Pharmaceutical Inc. Tetrahydrobiopterin prodrugs
US7888506B2 (en) * 2007-01-26 2011-02-15 Duquesne University Of The Holy Spirit Composition, synthesis, and use of a new class of fluorophores
JP2011508781A (ja) 2008-01-07 2011-03-17 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンの合成方法
US20110009629A1 (en) * 2008-02-26 2011-01-13 Sandoz Ag Preparation of morpholine derivatives
SG192826A1 (en) 2011-02-18 2013-09-30 Alexion Pharma Internat Sarl Methods for synthesizing molybdopterin precursor z derivatives

Also Published As

Publication number Publication date
EP2675278A1 (en) 2013-12-25
EP2675278A4 (en) 2014-08-20
CA2827679A1 (en) 2012-08-23
US20140303367A1 (en) 2014-10-09
AU2012219292B2 (en) 2015-03-05
ES2569252T3 (es) 2016-05-09
AU2012219292A1 (en) 2013-03-14
IL227917A0 (en) 2013-09-30
TW201241005A (en) 2012-10-16
CO7071121A2 (es) 2014-09-30
AR085291A1 (es) 2013-09-18
JP2014510054A (ja) 2014-04-24
WO2012112922A1 (en) 2012-08-23
MX2013009501A (es) 2014-02-03
US9260462B2 (en) 2016-02-16
EA201391206A1 (ru) 2014-02-28
CA2827679C (en) 2020-06-02
NZ614009A (en) 2014-08-29
SG192826A1 (en) 2013-09-30
EP2675278B1 (en) 2016-02-17
US20140323726A1 (en) 2014-10-30
KR20140007431A (ko) 2014-01-17
JP5972911B2 (ja) 2016-08-17

Similar Documents

Publication Publication Date Title
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
UY33227A (es) Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
UY38712A (es) Lactamas fusionadas de arilo y heteroarilo
CO6710897A2 (es) Derivados de poperdinona como inhibidores mdm2 para el tratamiento del cáncer
BR112013020864A2 (pt) métodos para sintetizar derivados de precursor z de molibdopterina
EA201201378A1 (ru) Определенные аминопиримидины, композиции на их основе и способы их использования
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201270752A1 (ru) Ингибиторы киназы и способ лечения злокачественной опухоли с их помощью
MY164776A (en) Heterocyclic compound
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
MX338551B (es) Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa.
BR112012029647A2 (pt) novos derivados de pirimidinas
EA201490754A1 (ru) Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора
IN2013MN02170A (pt)
MY169028A (en) Process for making hydroxylated cyclopentylpyrimidine compounds
CY1117087T1 (el) Διαδικασια για την παρασκευη εστερων (5-φθορο-2-μεθυλο-3-κινολιν-2-υλμεθυλ-ινδoλ-1-υλ)- οξικου οξεος
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
IN2014DN06192A (pt)
UY32748A (es) 2-carboxamida-cicloamino-ureas
EA201001566A1 (ru) Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний
UY32747A (es) 2-carboxamida-cicloamino-ureas sustituidas
ECSP13012548A (es) Inhibidores de oxadiazol de la producción de leucotrienos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.